Methotrexate Injection, Solution
Product Images NDC 61703-350

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 61703-350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methotrexate 01

FDA Label Image

Methotrexate 02

FDA Label Image

Methotrexate 03

FDA Label Image

Methotrexate 04

Methotrexate 04
This is a label for a 2mL sterile injection of Methotrexate, a cytotoxic agent. The manufacturer is Hospira, Inc. It contains 50 mg/2mL of isotonic liquid with a preservative. The full prescribing information and storage instructions can be found in the insert.*
FDA Label Image

Methotrexate 05

FDA Label Image

Methotrexate 06

Methotrexate 06
This is a description of a medication called Methotrexate, which is supplied in a sterile 40 ml single-dose vial. It is a hazardous drug for intravenous, intramuscular, subcutaneous, and intrathecal use only. The medication is preservative-free and contains 25 mg/mL of Methotrexate. The lot number is S014321AA and the expiration date format is YYYYMMMDD. The storage instructions are to keep it at 20°C to 25°C. It is important to discard any unused portion of the medication and to protect it from light.*
FDA Label Image

Methotrexate 07

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.